Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions.
Casadei Gardini A, Tenti E, Masini C, Nanni O, Scarpi E, Valgiusti M, Restuccia S, Gallani ML, Palazzini S, Bianchini E, Menozzi S, Maugeri A, Amadori D, Minguzzi M, Frassineti GL.
Casadei Gardini A, et al. Among authors: nanni o.
Oncotarget. 2016 Jun 28;7(26):40719-40724. doi: 10.18632/oncotarget.8942.
Oncotarget. 2016.
PMID: 27119511
Free PMC article.